These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19732500)

  • 1. A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments.
    Austin PD; Elia M
    J Pharm Pharm Sci; 2009; 12(2):233-42. PubMed ID: 19732500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of the risk of microbial contamination of parenteral doses prepared under aseptic techniques in clinical and pharmaceutical environments: an update.
    Austin PD; Hand KS; Elia M
    J Hosp Infect; 2015 Dec; 91(4):306-18. PubMed ID: 26164526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does your pharmacy have a compounding isolator?
    LaBella CJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved aseptic technique can reduce variable contamination rates of ward-prepared parenteral doses.
    Austin P; Elia M
    J Hosp Infect; 2013 Feb; 83(2):160-3. PubMed ID: 23313030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment.
    Larmené-Beld KHM; Frijlink HW; Taxis K
    Eur J Clin Pharmacol; 2019 May; 75(5):609-617. PubMed ID: 30683970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterile Product Packaging and Delivery Systems.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):491-500. PubMed ID: 26891564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial Identification in Pharmaceutical Compounding.
    Hyde T; Anstead J; Schade L; Zellner J
    Int J Pharm Compd; 2016; 20(1):13-8. PubMed ID: 27125052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contamination Control.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
    Stucki C; Sautter AM; Favet J; Bonnabry P
    Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
    Thomas M; Sanborn MD; Couldry R
    Am J Health Syst Pharm; 2005 Nov; 62(22):2386-92. PubMed ID: 16278330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.